{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:30:24Z","timestamp":1783042224185,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rmed.2021.106645","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T01:53:06Z","timestamp":1633744386000},"page":"106645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety"],"prefix":"10.1016","volume":"189","author":[{"given":"Samy","family":"Suissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9859","key":"10.1016\/j.rmed.2021.106645_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2021.106645_bib3","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease","year":"2019"},{"issue":"7","key":"10.1016\/j.rmed.2021.106645_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.clinthera.2010.06.022","volume":"32","author":"Blais","year":"2010","journal-title":"Clin. Therapeut."},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3111\/13696998.2011.622817","article-title":"Comparative effectiveness of budesonide\/formoterol and fluticasone\/salmeterol for COPD management","volume":"14","author":"Roberts","year":"2011","journal-title":"J. Med. Econ."},{"issue":"11","key":"10.1016\/j.rmed.2021.106645_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/joim.12067","article-title":"Combination of budesonide\/formoterol more effective than fluticasone\/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study","volume":"273","author":"Larsson","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.rmed.2021.106645_bib8","article-title":"Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting \u03b22 agonist: observational matched cohort study (PATHOS)","volume":"346","author":"Janson","year":"2013","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"issue":"1","key":"10.1016\/j.rmed.2021.106645_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-015-0210-x","article-title":"Comparative effectiveness of budesonide\/formoterol combination and fluticasone\/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study","volume":"16","author":"Kern","year":"2015","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.rmed.2021.106645_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.chest.2019.12.006","article-title":"Comparative safety and effectiveness of inhaled corticosteroid and long-acting \u03b2(2)-agonist combinations in patients with COPD","volume":"157","author":"Chang","year":"2020","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rmed.2021.106645_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.rmed.2021.106645_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2021.106645_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2021.106645_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15412555.2021.1877649","article-title":"Comparative effectiveness of initial LAMA versus LABA in COPD: real-world cohort study","volume":"18","author":"Suissa","year":"2021","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.rmed.2021.106645_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the general practice research database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.rmed.2021.106645_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib17","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: clinical practice research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106645_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.rmed.2021.106645_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005540","article-title":"Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)","volume":"4","author":"Quint","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.rmed.2021.106645_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02245-2016","article-title":"Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events","volume":"49","author":"Suissa","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2021.106645_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chest.2016.08.001","article-title":"Long-acting bronchodilator initiation in COPD and the risk of adverse cardiopulmonary events","volume":"151","author":"Suissa","year":"2017","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2021.106645_bib22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(18)30368-0","article-title":"Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study","volume":"6","author":"Suissa","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.chest.2019.03.005","article-title":"Comparative effectiveness and safety of LABA-LAMA vs LABA-ICS treatment of COPD in real-world clinical practice","volume":"155","author":"Suissa","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2021.106645_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.chest.2019.11.007","article-title":"Comparative effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: cohort study in real-world clinical practice","volume":"157","author":"Suissa","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2021.106645_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","article-title":"The incident user design in comparative effectiveness research","volume":"22","author":"Johnson","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.rmed.2021.106645_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pds.4107","article-title":"Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores","volume":"26","author":"Suissa","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.rmed.2021.106645_bib27","doi-asserted-by":"crossref","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.rmed.2021.106645_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151357","article-title":"Validation of the recording of acute exacerbations of COPD in UK primary care electronic Healthcare records","volume":"11","author":"Rothnie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2021.106645_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/CLEP.S117867","article-title":"Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records","volume":"8","author":"Rothnie","year":"2016","journal-title":"Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pds.3207","article-title":"Accuracy of pneumonia hospital admissions in a primary care electronic medical record database","volume":"21","author":"Meropol","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.rmed.2021.106645_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/COPD.S133891","article-title":"Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care","volume":"12","author":"Rothnie","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2021.106645_bib32","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2021.106645_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pds.4448","article-title":"GOLD assessment of COPD severity in the clinical practice research Datalink (CPRD)","volume":"28","author":"Rebordosa","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"10.1016\/j.rmed.2021.106645_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106645_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1164\/rccm.201005-0694OC","article-title":"Risks of pneumonia in patients with asthma taking inhaled corticosteroids","volume":"183","author":"O'Byrne","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112100353X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112100353X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:30:58Z","timestamp":1760617858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112100353X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S095461112100353X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106645","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106645"}}